Publications by authors named "Elena Trucco"
Article Synopsis
- A study found that individuals with celiac disease (CeD) perceive their risk of contracting COVID-19 differently from their actual risk, which is similar to the general population.
- The research involved a survey of over 10,000 CeD patients across 10 countries, collecting data on demographics, diet, and COVID-19 risk perceptions.
- Results showed that 56.1% of participants believed they had a higher risk of COVID-19, with those in celiac associations less likely to share this perception, and factors such as age and sex influencing their risk perception.
The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac Disease.
Clin Gastroenterol Hepatol
February 2021
The World Health Organization declared coronavirus disease-2019 (COVID-19) a global pandemic in March 2020. Since then, there are more than 34 million cases of COVID-19 leading to more than 1 million deaths worldwide. Numerous studies suggest that celiac disease (CeD), a chronic immune-mediated gastrointestinal condition triggered by gluten, is associated with an increased risk of respiratory infections.
View Article and Find Full Text PDFBackground: Evidence indicates that low-grade inflammation can alter gastrointestinal motor and sensory function and might contribute to the genesis of symptoms in IBS.
Objective: To examine relationships between IBS, disease antibodies and cytokine titers in celiac patients and a control group.
Materials And Methods: IBS, CD activity and serum levels of IL-6, IL-8 and IL12/23p40 were determined in celiac patients and controls.
Problem: Untreated celiac disease (CD) is often associated with early miscarriages, infertility, and alterations in menstrual cycle. Tissue transglutaminase (tTG) antibodies could be involved by interfering with tTG transamidating activity and/or biological functions mediated by its interaction with fibronectin (FN).
Method Of Study: The correlation between the presence of extra-digestive disorders and the reactivity of sera against tTG-FN and its effects on tTG transamidating activity was analyzed in a group or 50 women with recently diagnosed CD.